Gamco Investors INC. ET AL decreased its holdings in Albemarle Co. (NYSE:ALB) by 3.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,860 shares of the specialty chemicals company’s stock after selling 1,000 shares during the period. Gamco Investors INC. ET AL’s holdings in Albemarle were worth $3,691,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Jennison Associates LLC boosted its stake in shares of Albemarle by 1.0% in the fourth quarter. Jennison Associates LLC now owns 7,876,682 shares of the specialty chemicals company’s stock worth $1,007,349,000 after acquiring an additional 79,606 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Albemarle by 258.1% in the third quarter. Bank of New York Mellon Corp now owns 4,561,987 shares of the specialty chemicals company’s stock worth $621,845,000 after acquiring an additional 3,287,989 shares during the period. Janus Henderson Group PLC boosted its stake in shares of Albemarle by 95.3% in the third quarter. Janus Henderson Group PLC now owns 1,595,684 shares of the specialty chemicals company’s stock worth $217,507,000 after acquiring an additional 778,649 shares during the period. Allianz Asset Management GmbH boosted its stake in shares of Albemarle by 98.8% in the third quarter. Allianz Asset Management GmbH now owns 1,307,904 shares of the specialty chemicals company’s stock worth $178,281,000 after acquiring an additional 650,158 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in Albemarle by 113.6% during the third quarter. JPMorgan Chase & Co. now owns 975,732 shares of the specialty chemicals company’s stock valued at $129,109,000 after buying an additional 518,990 shares during the last quarter. 88.16% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts recently commented on ALB shares. Oppenheimer increased their price target on Albemarle from $133.00 to $157.00 and gave the company an “outperform” rating in a research note on Monday, October 16th. KeyCorp increased their price target on Albemarle from $125.00 to $150.00 and gave the company a “buy” rating in a research note on Monday, October 16th. Zacks Investment Research raised Albemarle from a “hold” rating to a “buy” rating and set a $157.00 price target for the company in a research note on Tuesday, October 17th. Royal Bank of Canada reissued a “buy” rating and set a $149.00 price target on shares of Albemarle in a research note on Wednesday, October 18th. Finally, Jefferies Group reissued a “buy” rating on shares of Albemarle in a research note on Tuesday, October 24th. Ten research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $127.88.

Shares of Albemarle Co. (ALB) opened at $107.72 on Friday. The stock has a market capitalization of $11,902.63, a P/E ratio of 26.66, a PEG ratio of 1.42 and a beta of 1.56. Albemarle Co. has a one year low of $90.35 and a one year high of $144.99. The company has a quick ratio of 1.56, a current ratio of 2.11 and a debt-to-equity ratio of 0.35.

COPYRIGHT VIOLATION NOTICE: “Albemarle Co. (ALB) Stake Decreased by Gamco Investors INC. ET AL” was originally published by Watch List News and is owned by of Watch List News. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.watchlistnews.com/albemarle-co-alb-stake-decreased-by-gamco-investors-inc-et-al/1859287.html.

Albemarle Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.